12/16/2025
Respiratory syncytial virus (RSV) is a highly contagious virus that circulates from fall to spring, typically peaking in the winter. It causes inflammation in the lower airways, along with difficulty breathing, wheezing, coughing and fever.
The virus can be especially dangerous for infants and young children and may lead to hospitalization. To help protect against the virus, it’s encouraged eligible children receive RSV monoclonal antibodies.
It’s available for:
• Infants younger than 8 months of age born to mothers who did not receive a maternal RSV vaccine during pregnancy.
• Infants and young children aged 8-19 months who are at an increased risk of severe RSV disease.
Learn more about RSV and who is eligible for immunizations: https://www.marshfieldclinic.org/immunizations/rsv